Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • yksikaksi
    Member
    • Dec 2009
    • 20

    #1

    What is the differences between pre-filtering vs PCR duplicates remove mapped reads?

    Hello,

    Does is a must to preform pre-filtering for color space reads before mapping?

    Could it has a big differences in downstream analysis when I mapped the SOLiD color space reads without pre-filtering but removed the PCR duplicates with Picard tool from mapped reads?

    Could anyone kindly please share with me your opinion?

    Thank you. Have a nice day.
  • kopi-o
    Senior Member
    • Feb 2008
    • 319

    #2
    I think you first have to clarify more precisely what you mean by pre-filtering, before we can answer.

    Comment

    • yksikaksi
      Member
      • Dec 2009
      • 20

      #3
      Sorry for the unclear question.

      The pre-filtering I refer here is view the reads with tools for example FastQC or Fastx and then trim out the so-called bad bases before mapping the reads.

      The problem is the FastQC and Fastx are develop to handle reads generated from Illumina and 454 platform. The color space (csfasta) reads can't be imported directly to these tools.

      Some Perl conversation scripts also having problem when convert the csfasta to fastq.

      Thanks.

      Comment

      • kopi-o
        Senior Member
        • Feb 2008
        • 319

        #4
        OK. So, pre-filtering (I would call it quality filtering) is distinct from duplicate removal and you can think of them as independent filtering steps.

        For SOLiD specific quality filtering, and looking at the data in a somewhat similar way to FastQC, I have used this toolkit: http://hts.rutgers.edu/filter/
        Then you don't need to convert to FASTQ.

        For some types of analysis, you may not need to do quality filtering (e g ChIP-seq, RNA-seq). The bad reads will (in general) simply fail to map. For de novo assembly, or resequencing where variant calling is important, you should do quality filtering.

        Comment

        • yksikaksi
          Member
          • Dec 2009
          • 20

          #5
          Originally posted by kopi-o View Post
          OK. So, pre-filtering (I would call it quality filtering) is distinct from duplicate removal and you can think of them as independent filtering steps.

          For SOLiD specific quality filtering, and looking at the data in a somewhat similar way to FastQC, I have used this toolkit: http://hts.rutgers.edu/filter/
          Then you don't need to convert to FASTQ.

          For some types of analysis, you may not need to do quality filtering (e g ChIP-seq, RNA-seq). The bad reads will (in general) simply fail to map. For de novo assembly, or resequencing where variant calling is important, you should do quality filtering.
          Thanks, kopi-o.

          I'm doing RNA-seq analysis with SOLiD platform. I read people mentioned carry out quality filtering (someone also called it as pre-filtering) before mapping is recommended. However, not much about how to deal with SOLiD csfasta but Illumina and 454 reads.

          Thanks for the information. It is useful!

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
            by SEQadmin2




            NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
            Today, 06:46 AM
          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 10-28-2026, 09:57 AM
          0 responses
          24 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-28-2026, 09:51 AM
          0 responses
          15 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-22-2026, 11:13 AM
          0 responses
          68 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-22-2026, 10:48 AM
          0 responses
          48 views
          0 reactions
          Last Post SEQadmin2  
          Working...